A Case of Doxifluridine-Induced Ro/SSA-Positive Cutaneous Lupus Erythematosus.
- Author:
Ji Youn SONG
1
;
Mi Yeon KIM
;
Hyung Ok KIM
;
Young Min PARK
Author Information
1. Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea. knderma@cmc.cuk.ac.kr
- Publication Type:Case Report
- Keywords:
Drug-induced lupus erythematosus;
Doxifluridine;
Anti-Ro/SSA
- MeSH:
Male;
Humans;
Stomach Neoplasms
- From:Korean Journal of Dermatology
2004;42(7):936-938
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Anti-Ro/SSA antibody positive drug-induced lupus erythematosus is characterized by erythematous papules at the photodistributed area after drug intake, positive anti-Ro/SSA antibody tests and histopathologic features of lupus erythematosus. A 68-year-old man was referred to our clinic with multiple erythematous violacious plaques on the face of 2 months' duration. After surgical removal of stomach cancer, he had been taking doxifluridine for 10 months. A histopathologic study revealed findings consistent with lupus erythematosus and the anti-Ro/SSA antibody was positive on the serologic test. Based on these findings, we diagnosed this case as anti-Ro/SSA antibody positive drug-induced lupus erythematosus, and report it with review of the literature.
